Drug class
Antitussives (Opioid Antitussives and DM)
The phrase "Antitussives (Opioid Antitussives and DM)" represents a combined functional category rather than a single standardized pharmacological class, grouping centrally acting opioid suppressants—principally codeine and hydrocodone—with dextromethorphan (DM), a synthetic morphinan derivative. Read more about Antitussives (Opioid Antitussives and DM)
1,151 drugs in this class 155 manufacturers
Drugs in Antitussives (Opioid Antitussives and DM)
LONG ACTING COUGH (dextromethorphan HBr)
MUCUS RELIEF COLD-FLU (phenylephrine HCl/dextromethorphan HBr/acetaminophen/guaifen)
MUCUS RELIEF CONGEST-COUGH (guaifenesin/dextromethorphan HBr/phenylephrine)
MUCUS RELIEF DM MAX ER (guaifenesin/dextromethorphan HBr)
MUCUS RELIEF MAX (guaifenesin/dextromethorphan HBr)
MUCUS RELIEF SINUS PAIN COUGH (phenylephrine HCl/dextromethorphan HBr/acetaminophen/guaifen)
MUCUS RLF COLD-FLU-SORE THROAT (phenylephrine HCl/dextromethorphan HBr/acetaminophen/guaifen)
NIGHTTIME MAX COLD-FLU (dextromethorphan HBr/phenylephrine/acetaminophen/doxylamine)
The phrase "Antitussives (Opioid Antitussives and DM)" represents a combined functional category rather than a single standardized pharmacological class, grouping centrally acting opioid suppressants—principally codeine and hydrocodone—with dextromethorphan (DM), a synthetic morphinan derivative.
These agents act primarily within the central nervous system to elevate the cough reflex threshold in the brainstem, with opioids stimulating central mu-opioid receptors and dextromethorphan exerting non-opioid antitussive effects largely via sigma-1 receptor agonism and NMDA receptor antagonism.
Clinically, medications in this grouping are indicated for the short-term, symptomatic suppression of nonproductive cough associated with acute upper respiratory tract infections, allergies, and bronchitis.
-
fda.gov
The phrase "Antitussives (Opioid Antitussives and DM)" represents a combined functional category rather than a single standardized pharmacological class, grouping centrally acting opioid suppressants—principally codeine and hydrocodone—with dextromethorphan (DM), a synthetic morphinan derivative These agents act primarily within the central nervous system to elevate the cough reflex threshold in the brainstem, with opioids stimulating central mu-opioid receptors and dextromethorphan exerting non...
-
fda.gov
The phrase "Antitussives (Opioid Antitussives and DM)" represents a combined functional category rather than a single standardized pharmacological class, grouping centrally acting opioid suppressants—principally codeine and hydrocodone—with dextromethorphan (DM), a synthetic morphinan derivative
-
drugbank.com
The phrase "Antitussives (Opioid Antitussives and DM)" represents a combined functional category rather than a single standardized pharmacological class, grouping centrally acting opioid suppressants—principally codeine and hydrocodone—with dextromethorphan (DM), a synthetic morphinan derivative These agents act primarily within the central nervous system to elevate the cough reflex threshold in the brainstem, with opioids stimulating central mu-opioid receptors and dextromethorphan exerting non...
-
nih.gov
These agents act primarily within the central nervous system to elevate the cough reflex threshold in the brainstem, with opioids stimulating central mu-opioid receptors and dextromethorphan exerting non-opioid antitussive effects largely via sigma-1 receptor agonism and NMDA receptor antagonism
-
nih.gov
Clinically, medications in this grouping are indicated for the short-term, symptomatic suppression of nonproductive cough associated with acute upper respiratory tract infections, allergies, and bronchitis
Sign in to follow this class
Following a drug class requires a free Physicians Office Resource account.